Immune Systems Advisor

Can you test for spike protein in your body or blood? Most of you will know “the spike protein” as the now infamous culprit behind much of the harm caused to long COVID and long vax sufferers. If you’ve found yourself wondering how much of that nasty stuff you might have in your system, you are not alone. Given the current spotlight on the spike protein, it’s no wonder it’s on everyone’s mind: Increased Awareness:  With the wealth of new studies and discussions, public awareness about the spike protein’s role has surged. Shedding  Phenomenon:  Recent insights into how the spike protein can be shared among individuals have heightened concerns. As a result, more than a few people wonder if you can test for the spike protein. In this post, we’ll set the record straight.  Can You Test For Spike Proteins? Here are some quick points to be aware of: There is no test for the spike protein, only “spike protein antibodies”. ...

Gov. Greg Abbott signed a bill ( filed in August 2025 ) that makes ivermectin — a drug used mostly in this country to treat livestock for parasites — available to Texans without a prescription. Texas is now the fifth state to approve the over-the-counter sale of the drug after it became popular as an unproven treatment for COVID-19.  House Bill 25  filed by state Rep.  Joanne Shofner , R-Nacogdoches, first passed the House, 87-47, after an energetic, three-hour debate along party lines. Shofner, surrounded by more than 20 Republicans at one point, argued her bill was championing medical freedom, giving Texans better access to a drug particularly outside cities where pharmacies outnumber physicians. Shofner's   bill does not put ivermectin on pharmacy shelves, but the drug would be available upon request from behind the pharmacist’s counter as Texans already do for other drugs, like Sudafed. The law takes effect Dec. 4, 2025. “It's absolutely im...

Spike protein disease refers to the pathological effects of the SARS-CoV-2 spike protein, including acute infection via ACE2 receptor binding, syncytia formation, and chronic sequelae like oxidative stress, inflammation, mitochondrial dysfunction, and cytokine storms. Both niclosamide (an FDA-approved anthelmintic) and methylene blue (an FDA-approved redox agent) are repurposed drugs with antiviral properties against SARS-CoV-2, including variants like Omicron. They target different aspects of spike-mediated pathology: methylene blue excels in direct spike inhibition and toxicity mitigation, while niclosamide focuses on viral entry and clearance. Below is a structured comparison based on preclinical and clinical data as of September 2025. Primary Mechanisms Niclosamide : Acts as a protonophore to neutralize endosomal pH, blocking viral internalization and replication. Inhibits TMEM16 proteins, preventing spike-induced syncytia formation and platelet activation. Targets CD147 receptor t...